A combination of 1α,25-dihydroxyvitamin D3, a plant-derived antioxidant and an inhibitor of the Cot1/Tlp2 oncogene as molecularly targeted weapons in the hematologist's battle against acute myeloid leukemias

Comment on: Wang X, et al. Cell Cycle 2010; 9:4542-51.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cell cycle (Georgetown, Tex.) Tex.), 2010-12, Vol.9 (23), p.4612-4612
Hauptverfasser:	Hughes, Philip J., Brown, Geoffrey
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antioxidants - therapeutic use Binding Biology Bioscience Calcitriol - therapeutic use Calcium Cancer Cell Cell Differentiation Cycle Humans Landes Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - enzymology MAP Kinase Kinase Kinases - antagonists & inhibitors MAP Kinase Kinase Kinases - metabolism Organogenesis Protein Kinase Inhibitors - therapeutic use Proteins Proto-Oncogene Proteins - antagonists & inhibitors Proto-Oncogene Proteins - metabolism Signal Transduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Comment on: Wang X, et al. Cell Cycle 2010; 9:4542-51.
ISSN:	1538-4101 1551-4005
DOI:	10.4161/cc.9.23.13932